U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Drug Safety and Availability
  4. Postmarket Drug Safety Information for Patients and Providers
  5. Methadone Hydrochloride (marketed as Dolophine) Information
  1. Postmarket Drug Safety Information for Patients and Providers

Methadone Hydrochloride (marketed as Dolophine) Information

Dolohine is a strong prescription pain medicine that contains methadone, an opioid (narcotic) that is used to treat moderate to severe around-the-clock pain. Dolophine is also used used to manage drug addiction.

 


 

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA MedWatch program, using the contact information at the bottom of this page.

Related Information

Regulatory History and Labeling from Drugs@FDA

Back to Top